Replies to post #92236 on Biotech Values

[DewDiligence]

The only tangible result has been more and more disagreements about what a pre-pre-heart attack is, without any tangible impact on patient care (other than plenty of useless testing).

There’s a feature story on this in Thursday’s WSJ—just in time for the ACC meeting :- ) I’ll post the article if anyone here is interested.

[biomaven0]

I think we must then have a disagreement on the meaning of the made-up word 'theranostics" - my understanding of the common usage was that it is about helping the decision of what treatment to use based on some refined diagnosis (typically some biomarker) - hence the combination of "therapy" and "diagnostics."

Peter